Where does Stichting Sanquin Bloedvoorziening rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Stichting Sanquin Bloedvoorziening ranks #19,191 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Stichting Sanquin Bloedvoorziening hold?

Stichting Sanquin Bloedvoorziening holds 15 US utility patents granted between 2015 and 2024, spanning 9 technology areas.

What is Stichting Sanquin Bloedvoorziening's Innovation Score?

Stichting Sanquin Bloedvoorziening has an Innovation Score of 39.0 out of 100 (top 39% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Stichting Sanquin Bloedvoorziening focus on?

Stichting Sanquin Bloedvoorziening's top technology area is C07K (Peptides) with 11 patents, ranking #825 of 3,615 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Stichting Sanquin Bloedvoorziening's patent grant rate increasing or decreasing?

Stichting Sanquin Bloedvoorziening's recent grant velocity is -33% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Stichting Sanquin Bloedvoorziening's patents?

Stichting Sanquin Bloedvoorziening's patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Stichting Sanquin Bloedvoorziening patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Stichting Sanquin Bloedvoorziening

USPTO PatentsView assignee record - 15 granted patents across 9 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Stichting ranks #19,191 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 9 technology areas.

#19,191
of 49,997 US assignees by volume: Top 39%
by Innovation Score (39.0/100): 16.5
avg claims per patent: -33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19191 · Foreign Corporation #19,191 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,191/49,997
PHOTO-FINISH State Grid Tianjin…
CPC-NARROW C07K · 9 areas
INNOV-THIN 39.0/100
CLAIMS-RICH 16.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: State Grid Tianjin Electric Power Company (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stichting’s 39.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (25%) Velocity 8.9 pts (23%) Breadth 10.6 pts (27%) Claim depth 9.9 pts (25%)

Qualcomm Incorporated · highest

85
Stichting Sanquin… · this assignee

39
3D Lighting… · lowest

7

What this shows Stichting's Innovation Score is 39.0/100 (top 39% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Stichting?

Each dot is one of Stichting’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stichting’s own 16.5 claims/patent is ABOVE the 13.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Stichting vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stichting's grants concentrate

Stichting Sanquin Bloedvoorziening is a focused PatentsView assignee: 9 CPC subclasses with 73.3% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2016. By volume, Stichting sits between State Grid Tianjin Electric Power Company and Stryker Trauma GmbH.

Stichting's three-year grant acceleration

Stichting Sanquin Bloedvoorziening shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

State Grid Tianji…

15
Steadymed

15
Steam Tech

15
Stichting Dienst…

15
Stout Medical Gro…

15
Streater

15
Stryker Spine

15
Stryker Trauma

15
Stichting Sanquin… ◀

15

What this shows Stichting holds 15 patents at rank #19,191, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Stichting

By rank, the assignees closest to #19,191 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Stichting's primary technology class.

Stichting's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 39% higher than 61% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Stichting Sanquin Bloedvoorziening patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	20.0%
2016	1	6.7%
2017	2	13.3%
2018	2	13.3%
2019	1	6.7%
2021	2	13.3%
2022	1	6.7%
2023	1	6.7%
2024	2	13.3%

Which technologies does Stichting Sanquin Bloedvoorziening patent most?

C07K - Peptides 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Stichting Sanquin Bloedvoorziening's patent record in context - here's where to go next.

Stichting Sanquin Bloedvoorziening's lead technology class is C07K (Peptides), 73.3% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #19,191 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Stichting Sanquin Bloedvoorziening against State Grid Tianjin Electric Power Company, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.